The Subscription Receipts were issued by the Company on December 6, 2022. You may get these documents for free by visiting EDGAR on the SEC web site at and SEDAR at Alternatively, the Company, any underwriter or any dealer participating in the Offering will arrange to send you the prospectus for the Offering (and any amendment thereto) if you request it in Canada from Canaccord Genuity Corp., 40 Temperance Street, Suite 2100, Toronto, ON M5H 0B4 and in the United States from Canaccord Genuity LLC, 99 High Street, Suite 1200, Boston, Massachusetts 02110, Attn: Syndicate Department, by telephone at (617) 371-3900, or by email at addition, the Company has agreed to file a preliminary short form prospectus to qualify 23,277,000 units ("Subscription Receipt Units") of the Company to be issued up conversion of 23,277,000 previously issued subscription receipts (the "Subscription Receipts"). There will not be any sale or acceptance of an offer to buy the securities until a receipt for the final prospectus has been issued and the Registration Statement becomes effective.īefore you invest, you should read the prospectus (and any amendment thereto) in that Registration Statement and other documents the Company has filed with the SEC for more complete information about the Company and this Offering. The preliminary prospectus for the Offering (and any amendment thereto) is still subject to completion and amendment. The preliminary short form prospectus (and any amendment thereto) and the Registration Statement contain important detailed information relating to the Company and the Offering. ![]() Securities and Exchange Commission (the "SEC") for the offering to which this communication relates but has not yet become effective an amendment to such registration statement will also be filed, including an amendment to the short form prospectus for the Offering (as amended, the "Registration Statement"). A registration statement on Form F-10 relating to the Offering (including such prospectus) has also been filed with the U.S. The preliminary short form prospectus for the Offering has been filed, and an amendment to the preliminary short form prospectus containing the definitive terms of the Offering will be filed, with the securities commissions or similar securities regulatory authorities in each of the provinces of Canada except Québec. ![]() In addition, if the Company is not able to complete a potential loan transaction contemplated by a non-binding term sheet prior to February 15, 2023, the Company expects to use a portion of the proceeds from the Offering to fund amounts required to be paid to complete the Company's previously announced pending acquisition of the Alta Mesa ISR uranium project (the "Alta Mesa Acquisition").Ĭlosing of the Offering, which is expected on or about Febru(the "Closing Date"), is subject to market and other customary conditions, including approvals of the TSX Venture Exchange and the NYSE American. The Company expects to use the net proceeds from the Offering to maintain and advance the Company's material properties, acquire properties, plant upgrades, drilling, maintenance and refurbishment, community outreach and communications, licensing and permitting and for general corporate and working capital purposes in the manner as set forth in the preliminary short form prospectus. In addition, the Company has granted the Underwriters an option to purchase up to an additional 1,384,650 Units on the same terms and conditions exercisable at any time, in whole or in part, until 30 days following the Closing Date, for market stabilization purposes and to cover over-allotments, if any. Each Warrant will entitle the holder thereof to purchase one common share of the Company (a "Warrant Share") for a period of 36 months following the Closing Date (as defined herein) of the Offering at an exercise price of C$4.05 per Warrant Share, subject to adjustment in certain events. (" enCore" or the " Company") (NYSE American: EU) (TSXV: EU) in connection with its previously announced overnight marketed offering (the "Offering") today announced that it has entered into an underwriting agreement with Canaccord Genuity as lead underwriter, together with a syndicate of underwriters (the "Underwriters") for the sale of 9,231,000 units of the Company (the "Units") at a price of C$3.25 per Unit for total gross proceeds to the Company of approximately C$30 million.Įach Unit will consist of one common share in the capital of the Company (each a "Unit Share") and one-half of one common share purchase warrant (a "Warrant").
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |